Clinical trial
Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma
NCT06528847
Study timeline
Study start (actual)2024-06-05Date precision: day
Registry last updated2024-07-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-Small Cell Lung Cancerunresolved
Interventions
BenmelstobartDRUG
Sponsors & collaborators
Shanghai Pulmonary Hospital, Shanghai, Chinalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06528847 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.